Pharmacogenomics in Psychiatry examines how genetic variations affect individual responses to psychiatric medications. It covers the identification of biomarkers that predict treatment efficacy and adverse effects in disorders like depression and schizophrenia. The book emphasizes personalized treatment plans to enhance patient outcomes and reduce trial-and-error prescribing. Ideal for psychiatrists and pharmacogenomic specialists, it advances the precision of mental health therapies.
Ryan Turner specializes in pharmacogenomics in psychiatry, focusing on how genetic factors influence psychiatric medication responses. His work includes studying the genetic basis for variability in drug efficacy and adverse reactions in patients with mental health disorders. Ryan advocates for using pharmacogenomic testing to personalize psychiatric treatments and improve patient outcomes. He trains mental health professionals to incorporate pharmacogenomic data into treatment plans for more effective management of psychiatric conditions.